Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Profilin 1 delivery tunes cytoskeletal dynamics toward CNS axon regeneration
Rita Pinto-Costa, Sara C. Sousa, Sérgio C. Leite, Joana Nogueira-Rodrigues, Tiago Ferreira da Silva, Diana Machado, Joana Marques, Ana Catarina Costa, Márcia A. Liz, Francesca Bartolini, Pedro Brites, Mercedes Costell, Reinhard Fässler, Mónica M. Sousa
Rita Pinto-Costa, Sara C. Sousa, Sérgio C. Leite, Joana Nogueira-Rodrigues, Tiago Ferreira da Silva, Diana Machado, Joana Marques, Ana Catarina Costa, Márcia A. Liz, Francesca Bartolini, Pedro Brites, Mercedes Costell, Reinhard Fässler, Mónica M. Sousa
View: Text | PDF
Research Article Cell biology Neuroscience

Profilin 1 delivery tunes cytoskeletal dynamics toward CNS axon regeneration

  • Text
  • PDF
Abstract

After trauma, regeneration of adult CNS axons is abortive, causing devastating neurologic deficits. Despite progress in rehabilitative care, there is no effective treatment that stimulates axonal growth following injury. Using models with different regenerative capacities, followed by gain- and loss-of-function analysis, we identified profilin 1 (Pfn1) as a coordinator of actin and microtubules (MTs), powering axonal growth and regeneration. In growth cones, Pfn1 increased actin retrograde flow, MT growth speed, and invasion of filopodia by MTs, orchestrating cytoskeletal dynamics toward axonal growth. In vitro, active Pfn1 promoted MT growth in a formin-dependent manner, whereas localization of MTs to growth cone filopodia was facilitated by direct MT binding and interaction with formins. In vivo, Pfn1 ablation limited regeneration of growth-competent axons after sciatic nerve and spinal cord injury. Adeno-associated viral (AAV) delivery of constitutively active Pfn1 to rodents promoted axonal regeneration, neuromuscular junction maturation, and functional recovery of injured sciatic nerves, and increased the ability of regenerating axons to penetrate the inhibitory spinal cord glial scar. Thus, we identify Pfn1 as an important regulator of axonal regeneration and suggest that AAV-mediated delivery of constitutively active Pfn1, together with the identification of modulators of Pfn1 activity, should be considered to treat the injured nervous system.

Authors

Rita Pinto-Costa, Sara C. Sousa, Sérgio C. Leite, Joana Nogueira-Rodrigues, Tiago Ferreira da Silva, Diana Machado, Joana Marques, Ana Catarina Costa, Márcia A. Liz, Francesca Bartolini, Pedro Brites, Mercedes Costell, Reinhard Fässler, Mónica M. Sousa

×

Figure 3

Pfn1 depletion in vivo decreases axonal regeneration and functional recovery.

Options: View larger image (or click on image) Download as PowerPoint
Pfn1 depletion in vivo decreases axonal regeneration and functional reco...
(A) Neuronal Thy1 promoter drives Cre recombinase and YFP expression in cre+Pfn1 mice after tamoxifen administration, leading to Pfn1 exon1 excision. (B) βIII-tubulin staining of cre+Pfn1 adult DRG neurons in the presence or absence of a Pfn2 shRNA–expressing plasmid. Scale bars: 50 μm. (C) Total neurite length and (D) branching analysis related to B. Only YFP+ (Pfn1-KO) neurons were quantified. Data represent mean ± SEM (n = 4–5 independent samples/condition; 5–35 neurons/sample). **P < 0.01; ***P < 0.001; ****P < 0.0001 by 1-way ANOVA with Tukey’s post hoc test (C) or 2-way ANOVA with Tukey’s post hoc test (D). (E) Strategy to assess PNS regeneration. (F) PPD-stained sciatic nerves from cre+Pfn1 mice, 7 and 15 days postinjury (PI). Scale bars: 20 μm. (G) Myelinated axon density related to F. Data represent mean ± SEM (n = 3–8 animals/condition). **P < 0.01 by Student’s t test. MFs, myelinated fibers. (H) 3D surface–rendered reconstructions of NMJs fluorescently labeled with α-bungarotoxin (BTX). Scale bars: 50 μm. (I) Zoom-ins of H. Scale bars: 10 μm. (J) Volume quantification of NMJs (28 days PI). Data represent mean ± SEM (n = 3 animals/condition). **P < 0.01 by Student’s t test. (K) Motor nerve conduction velocity (28 days PI). Data represent mean ± SEM (n = 4–6 animals/condition). **P < 0.01 by Student’s t test. (L) Strategy to assess CNS regeneration. (M) YFP+ (green)/CT-B+ (red) axons (arrowheads) in spinal cord following SCI in cre+Pfn1wt/wt and CL in either cre+Pfn1wt/wt or cre+Pfn1fl/fl mice. Scale bars: 50 μm. Dashed line, lesion border; r, rostral; c, caudal; d, dorsal; v, ventral. (N) Quantification of mean growth distance of YFP+ (Pfn1-KO) and YFP– ascending sensory axons (CT-B+ axons) from the rostral end of the injured dorsal column tract. Data represent mean ± SEM (n = 4–5 animals/condition). *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001 by 1-way ANOVA with Tukey’s post hoc test. NS, not significant.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts